Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qinggan Jieyu granule is a Traditional Chinese Medicine (TCM) formulation developed by the Yueyang Integrated Traditional Chinese and Western Medicine Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine. It is specifically designed for the treatment of primary insomnia. The formula follows the TCM therapeutic principle of clearing the liver and relieving stagnation (Qinggan Jieyu), which is intended to address sleep disturbances caused by liver-fire hyperactivity or emotional distress. It is typically administered as an oral granule. The efficacy and safety of the preparation have been investigated in prospective, randomized, double-blind, controlled clinical trials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qinggan jieyu granule.